Selected publication milestones, not an exhaustive history or discovery priority claim.
2003 — Small controlled warm/cold hydrotherapy bundle has selected heart-failure symptom/function effects without isolating modalities. Original PMID14564334.
2004 — Supervised sauna reduces measured ectopy in a small heart-failure trial; hard-event reduction remains a different outcome. Original PMID15564698.
2008 — Multicenter Waon report adds short-term disease-specific cardiac and symptom data, with many within-arm contrasts. Original PMID18922381.
2009 — Small supervised sauna crossover is tolerated but lacks significant between-arm function/QoL efficacy. Original PMID19154844.
2009 — Matched severe-heart-failure Waon follow-up reports a five-year HF/cardiac-death composite association; allocation and primary-prevention scope remain unresolved. Original PMID19304125.
2012 — Acute sauna/exercise hypertension comparisons address short-term hemodynamics. Original PMID22863164.
2015 — Finnish male cohort links baseline sauna frequency/duration with fatal events prospectively. Original PMID25705824.
2015 — Chronic cold recovery attenuates selected strength adaptation despite acute recovery rationale. Original PMID26174323.
2016 — WAON-CHF primaryBNP is null while selected secondary functional measures improve. Original PMID27001189.
2016 — Unblinded cold showers reduce self-reported absence rather than overall illness days. Original PMID27631616.
2018 — KIHD fitness/sauna joint analysis narrows measured confounding without creating independent exposure allocation. Original PMID28972808.
2018 — Older men-and-women Finnish cohort expands observational enrollment and adds fatal-event associations. Original PMID30486813.
2019 — PAD heat-plus-calisthenics versus exercise comparison shows functional improvement without clear between-arm superiority. Original PMID31002283.
2020 — Named home auricular device with active sensory comparator reduces objective AF burden in a defined disease trial. Original PMID32192678.
2022 — Exercise-plus-sauna randomized trial adds BP and estimated-fitness benefits over exercise. Original PMID35785965.
2023 — CAD randomized exposure achieves acclimation without the predicted vascular/BP benefit. Original PMID37650138.
2024 — Defined cervical-stimulation diabetes trial is clinically symptom-null despite broader vagal-treatment hypotheses. Original PMID38546822.
2024 — Specific sham-controlled auricular insomnia trial has clinically meaningful symptom effects. Original PMID39680406.
2025 — Cold/hot athlete recovery does not exceed placebo in measured acute and longer-term performance outcomes. Original PMID40498100.
2025 — Added hot-water exposure improves selected vascular/BP measures beyond exercise but not all cardiometabolic endpoints. Original PMID40719540.
2025 — Hyperacute-stroke device trial changes molecular/autonomic measures without its primaryBP-variability benefit. Original PMID41455014.
2026 — Open HFpEF sauna pilot shows function gains and partial loss after withdrawal, with a controlled trial described as planned. Original PMID41831305.
2026 — Acute CKD controlled sauna pilot shows selected function and vascular positives with limited horizon. Original PMID42113470.
Independent clinical-event causal evidence for habitual sauna, with repeated exposure and settings beyond the Finnish cohort family.
Whether BP/vascular/autonomic changes mediate events rather than simply coexist with exposure.
Sauna-alone versus exercise-plus-sauna and modality equivalence without substituting water immersion, infrared Waon or local heating.
Durable cold-health endpoints and indication-specific recovery/adaptation tradeoffs, with measured expectancy and adherence.
Exact consumer-device identity and indication-specific active-sham evidence; implanted, cervical and auricular stimulation cannot be interchanged by label.
Longer-term benefit-harm data in predefined disease and medication strata without converting supervised short tolerability into universal safety.
A multicenter randomized pragmatic sauna-plus-usual-care versus matched usual-care/time-contact study, or a validated independent access/withdrawal natural experiment, with adjudicated cardiovascular hospitalization, infarction, stroke and cardiovascular death over prespecified follow-up, stratifying baseline disease and exercise before outcomes.